| Human NK cells: surface receptors, inhibitory checkpoints, and translational applications |
44 |
| Targeting natural killer cells in solid tumors |
36 |
| NETosis, complement, and coagulation: a triangular relationship |
33 |
| When worlds collide: Th17 and Treg cells in cancer and autoimmunity |
33 |
| IDO1 in cancer: a Gemini of immune checkpoints |
27 |
| Chemokines in homeostasis and diseases |
26 |
| Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer |
26 |
| Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment |
25 |
| Helper T cell differentiation |
25 |
| TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy |
25 |
| The unique structural and functional features of CXCL12 |
24 |
| The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? |
24 |
| Autophagy in dendritic cells |
24 |
| The microbiome and autoimmunity: a paradigm from the gut-liver axis |
23 |
| Targeting PVR (CD155) and its receptors in anti-tumor therapy |
20 |
| The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia |
19 |
| Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE |
18 |
| Role of Hippo signaling in regulating immunity |
18 |
| Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses |
18 |
| Macrophage-derived IL-1 alpha promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity |
18 |
| Cell-cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models |
17 |
| The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection |
17 |
| Chemokine and chemotactic signals in dendritic cell migration |
17 |
| Tissue-resident lymphocytes: from adaptive to innate immunity |
17 |
| Safety, pharmacokinetics, and biomarkers of F- a recombinant human interleukin-22 dimer, in healthy subjects |
16 |
| Revolutionizing immunology with single-cell RNA sequencing |
16 |
| Innate lymphoid cell memory |
15 |
| Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells |
15 |
| The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation |
14 |
| MicroRNA-663 induces immune dysregulation by inhibiting TGF-beta 1 production in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus |
14 |
| Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy |
14 |
| Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity |
14 |
| The benefits of neuroinflammation for the repair of the injured central nervous system |
13 |
| The innate immune response to allotransplants: mechanisms and therapeutic potentials |
12 |
| miR-125b-5p and miR-99a-5p downregulate human gamma delta T-cell activation and cytotoxicity |
12 |
| Glucocorticoid receptor promotes the function of myeloid-derived suppressor cells by suppressing HIF1 alpha-dependent glycolysis |
12 |
| Three macrophage subsets are identified in the uterus during early human pregnancy |
12 |
| MicroRNA-99a mimics inhibit M1 macrophage phenotype and adipose tissue inflammation by targeting TNF alpha |
12 |
| Characterization and allergic role of IL-33-induced neutrophil polarization |
12 |
| MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production |
12 |
| IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3 |
11 |
| Guillain-Barre syndrome, transverse myelitis and infectious diseases |
11 |
| Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction |
11 |
| Genetic and epigenetic influences on the loss of tolerance in autoimmunity |
11 |
| Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16 |
10 |
| IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjogren's syndrome |
10 |
| Poly-gamma-glutamic acid from Bacillus subtilis upregulates pro-inflammatory cytokines while inhibiting NLRP NLRC4 and AIM2 inflammasome activation |
10 |
| Long noncoding RNAs in the metabolic control of inflammation and immune disorders |
9 |
| Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses |
9 |
| Th1 cytokines, true functional signatures for protective immunity against TB? |
9 |
